FDA confirms acceptability of Palatin's remaining Phase 3 pivotal clinical trials for PL9643 in DED
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
Boehringer Ingelheim to advance potential new treatment for geographic atrophy following positive Phase I results
Advancing the optimal diagnosis & treatment of thyroid eye disease
Ocuphire Pharma doses first patient in phase 3 VEGA-3 clinical trial
Researchers examine accuracy of a commonly used mobile ophthalmology application’s vision assessment tools
